Suppr超能文献

接受两性霉素B治疗的患者的尿腺苷排泄量。

Urinary adenosine excretion in patients receiving amphotericin B.

作者信息

Carlson M A, Ferraz A A, Condon R E

机构信息

Medical College of Wisconsin, Milwaukee 53226, USA.

出版信息

Surgery. 1997 Feb;121(2):190-3. doi: 10.1016/s0039-6060(97)90289-0.

Abstract

BACKGROUND

Intravenous amphotericin B (AMB) administration in animals causes renal vasoconstriction, ischemia, and oliguria that may result in irreversible renal injury; the mechanism of AMB nephrotoxicity may be similar in human beings. Adenosine is excreted in urine by the ischemic kidney. We hypothesized that adenosine excretion and oliguria would be a marker for patients who later would manifest AMB-associated renal insufficiency and that pre-AMB saline administration (which ameliorates AMB nephrotoxicity) would negate the change in adenosine excretion and urine output.

METHODS

Twenty hospitalized patients being treated at the direction of their attending physician and who were receiving AMB (15 to 75 mg intravenously) had urine collected for 1 hour before and for 2 hours during AMB infusion. Eleven patients received normal saline solution (500 ml intravenously) before the AMB infusion; the other nine formed the comparator group. An aliquot of each urine collection was precipitated with perchloric acid to remove protein and cellular elements and centrifuged, and the supernatant was assayed for adenosine by using high-pressure liquid chromatography.

RESULTS

Infusion of AMB was associated with a decrease in mean urine output both in patients who received saline solution (245 before versus 149 ml/hr during AMB infusion, p = 0.04) and in patients in comparator group (139 versus 89 ml/hr, p = 0.027). The mean urinary adenosine excretion was unchanged in the saline-loaded group (0.1354 before versus 0.1255 mmol/hr during drug infusion, p = 0.25) and was decreased in the comparator group (0.2276 versus 0.1127 mmol/hr, p = 0.01). Development of renal insufficiency did not correlate with the change in urine output or adenosine excretion.

CONCLUSIONS

AMB infusion in human beings results in decreased urine output and decreased adenosine excretion. The latter effect is prevented by a pre-AMB saline load. The changes in urine output and adenosine excretion are not predictive of the development of renal insufficiency.

摘要

背景

动物静脉注射两性霉素B(AMB)可导致肾血管收缩、缺血和少尿,这可能会导致不可逆的肾损伤;AMB肾毒性机制在人类中可能相似。腺苷由缺血的肾脏经尿液排出。我们推测,腺苷排泄和少尿可能是随后会出现AMB相关性肾功能不全患者的一个标志物,并且在注射AMB前给予生理盐水(可改善AMB肾毒性)会消除腺苷排泄和尿量的变化。

方法

20名在主治医生指导下住院并接受AMB治疗(静脉注射15至75mg)的患者,在AMB输注前1小时和输注期间2小时收集尿液。11名患者在AMB输注前接受生理盐水(静脉注射500ml);其他9名患者作为对照组。每次收集的尿液样本用高氯酸沉淀以去除蛋白质和细胞成分,然后离心,上清液用高压液相色谱法测定腺苷。

结果

接受生理盐水的患者(AMB输注前平均尿量为245ml/小时,输注期间为149ml/小时,p = 0.04)和对照组患者(分别为139ml/小时和89ml/小时,p = 0.027)在输注AMB后平均尿量均减少。生理盐水组平均尿腺苷排泄量无变化(药物输注前为0.1354mmol/小时,输注期间为0.1255mmol/小时,p = 0.25),而对照组则减少(分别为0.2276mmol/小时和0.1127mmol/小时,p = 0.01)。肾功能不全的发生与尿量或腺苷排泄的变化无关。

结论

人类输注AMB会导致尿量减少和腺苷排泄减少。AMB输注前给予生理盐水可防止后者的发生。尿量和腺苷排泄的变化不能预测肾功能不全的发生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验